Ironwood Pharmaceuticals (IRWD) Current Assets (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Current Assets of $332.3 million for Q1 2026, up 21.2% sequentially from $274.2 million in Q4 2025, and up 106.93% YoY from $160.6 million in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Current Assets (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Current Assets for 17 years, with the latest figure at $332.3 million in Q1 2026.
- Quarterly Current Assets rose 106.93% year-over-year to $332.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $332.3 million (up 106.93% YoY) and the FY2025 annual result came in at $274.2 million, up 50.34% from the prior year.
- Current Assets grew to $332.3 million in Q1 2026 per IRWD's latest filing, from $274.2 million in the prior quarter.
- Over five years, Current Assets peaked at $866.4 million in Q1 2023 and troughed at $160.6 million in Q1 2025.
- A 5-year average of $379.9 million and a median of $273.8 million in 2025 frame the typical range for Current Assets.
- The sharpest annual moves came in 2024 and 2026: Current Assets slumped 75.97% in 2024, then soared 106.93% in 2026.
- Over 5 years, Current Assets stood at $780.6 million in 2022, then sank by 70.12% to $233.3 million in 2023, then slipped by 21.83% to $182.4 million in 2024, then soared by 50.34% to $274.2 million in 2025, then gained by 21.2% to $332.3 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $332.3 million, $274.2 million, and $273.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 3.22 Bn |
| 10 | Ironwood Pharmaceuticals | 669.95 Mn | 590.82 Mn | - | 199.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 199.20 Mn |
| Mar 31, 2026 | 332.29 Mn |
| Dec 31, 2025 | 274.18 Mn |
| Sep 30, 2025 | 273.84 Mn |
| Jun 30, 2025 | 191.75 Mn |
| Mar 31, 2025 | 160.58 Mn |
| Dec 31, 2024 | 182.37 Mn |
| Sep 30, 2024 | 178.60 Mn |
| Jun 30, 2024 | 178.18 Mn |
| Mar 31, 2024 | 208.17 Mn |
| Dec 31, 2023 | 233.29 Mn |
| Sep 30, 2023 | 253.61 Mn |
| Jun 30, 2023 | 317.60 Mn |
| Mar 31, 2023 | 866.37 Mn |
| Dec 31, 2022 | 780.63 Mn |
| Sep 30, 2022 | 698.99 Mn |
| Jun 30, 2022 | 617.83 Mn |
| Mar 31, 2022 | 710.10 Mn |
| Dec 31, 2021 | 745.23 Mn |
| Sep 30, 2021 | 695.37 Mn |